Print

Asuragen, Inc. to Present at Upcoming Association for Molecular Pathology Annual Meeting on Genomic Medicine  
10/24/2012 9:23:13 AM

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a leader in molecular diagnostic technologies, will present at the upcoming Association for Molecular Pathology (AMP) Annual Meeting on Genomic Medicine, October 24-27, 2012 in Long Beach, CA. Asuragen’s scientific contributions will represent its broad expertise and development efforts in the areas of oncology, genetic testing, microRNA and next generation sequencing. Asuragen’s technologies will be featured in more than 10 presentations throughout the conference and the following studies will be reported by Asuragen and its collaborators:
//-->